BNP/CALL/CARDINAL HEALTH/95/0.1/21.06.24 Share Price

Warrant

DE000PC2XR82

Market Closed - Bid/Ask 20:50:33 23/05/2024 BST
0.3 EUR 0.00% Intraday chart for BNP/CALL/CARDINAL HEALTH/95/0.1/21.06.24
Current month-70.21%
1 month-71.72%
Date Price Change
23/05/24 0.3 0.00%
22/05/24 0.3 +7.14%
21/05/24 0.28 -33.33%
20/05/24 0.42 -17.65%
17/05/24 0.51 +2.00%

Real-time Boerse Frankfurt Warrants

Last update May 23, 2024 at 08:50 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying CARDINAL HEALTH, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC2XR8
ISINDE000PC2XR82
Date issued 04/01/2024
Strike 95 $
Maturity 21/06/2024 (29 Days)
Parity 10 : 1
Emission price 1.16
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.12
Lowest since issue 0.26
Delta0.24x
Omega 3.720
Premium89.17x
Gearing15.52x
Moneyness 0.5473
Difference Strike -1.05 $
Difference Strike %-1.11%
Spread 0.02
Spread %6.25%
Theoretical value 0.3100
Implied Volatility 211.26 %
Total Loss Probability 90.36 %
Intrinsic value 0.000000
Present value 0.3100
Break even 98.35 €
Theta-0.11x
Vega0x
Rho0x

Company Profile

Cardinal Health, Inc. is specialized in the distribution of products and health services to pharmacies, hospitals and medical practices. Net sales break down by activity as follows: - distribution of pharmaceutical products (92.7%); - distribution of medical, surgical and laboratory products (7.3%). The group also develops a manufacturing of medical and surgical products activity (masks, overalls, gloves, diagnostic products, products of aspiration and collection of liquids, radiology intervention, respiratory assistance, etc.). The United States accounts for 97.7% of net sales.
Sector
-
More about the company

Ratings for Cardinal Health, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Cardinal Health, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
96.32 USD
Average target price
111.8 USD
Spread / Average Target
+16.06%
Consensus